ONC insider filings

BeOne Medicines Ltd. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-12. Screen ONC transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 10 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Wang Xiaodong — Director5—34 legs · 131,370 sh · $46,836,8559
Lee Chan Henry — SVP, General Counsel2—3 legs · 2,230 sh · $865,035—
Ball Titus B. — Principal Accounting Officer2—3 legs · 1,691 sh · $679,2514
Wu Xiaobin — President and COO1—1 leg · 280 sh · $106,400—

Recent insider filings — BeOne Medicines Ltd.

FiledFormInsiderReported transactionsSource
2026-11-124Wang Xiaodong — DirectorGift (G): 1,183 @ $0EDGAR
2026-11-104Ball Titus B. — Principal Accounting OfficerOption exercise (M): 880 @ $207.55 · Option exercise (M): 679 @ $159.03 · Sale (S): 1,533 @ $405.55 · Sale (S): 26 @ $406.34 · Option exercise (M): 11,440 (derivative) @ $0 · Option exercise (M): 8,827 (derivative) @ $0EDGAR
2026-11-094Lee Chan Henry — SVP, General CounselSale (S): 660 @ $400 · Sale (S): 455 @ $402EDGAR
2026-10-294Wang Xiaodong — DirectorOption exercise (M): 31,028 @ $36.90 · Sale (S): 880 @ $355.56 · Sale (S): 1,440 @ $355.62 · Sale (S): 1,239 @ $357.54 · Sale (S): 1,681 @ $358.75 · Sale (S): 1,280 @ $359.72 · +7 moreEDGAR
2026-10-154Wang Xiaodong — DirectorOption exercise (M): 31,027 @ $36.90 · Sale (S): 7,167 @ $349.56 · Sale (S): 10,361 @ $350.47 · Sale (S): 5,681 @ $351.40 · Sale (S): 6,558 @ $352.57 · Sale (S): 1,260 @ $353.24 · +1 moreEDGAR
2026-10-024Lee Chan Henry — SVP, General CounselSale (S): 1,115 @ $375EDGAR
2026-09-304Wang Xiaodong — DirectorOption exercise (M): 31,028 @ $36.90 · Sale (S): 160 @ $356.97 · Sale (S): 120 @ $358.71 · Sale (S): 40 @ $359.16 · Sale (S): 2,241 @ $361.05 · Sale (S): 4,239 @ $362.17 · +6 moreEDGAR
2026-09-104Wang Xiaodong — DirectorSale (S): 1,181 @ $345.38 · Sale (S): 2,841 @ $346.16 · Sale (S): 1,517 @ $347.39 · Sale (S): 1,721 @ $348.01 · Option exercise (M): 31,027 @ $36.90 · Sale (S): 7,492 @ $348.31 · +4 moreEDGAR
2026-09-034Ball Titus B. — Principal Accounting OfficerSale (S): 132 @ $355.86EDGAR
2026-08-274Wu Xiaobin — President and COOSale (S): 280 @ $380EDGAR
2026-08-134Lee Chan Henry — SVP, General CounselOption exercise (M): 812 @ $194.47 · Option exercise (M): 1,058 @ $213.32 · Option exercise (M): 796 @ $159.03 · Sale (S): 2,666 @ $360 · Option exercise (M): 10,556 (derivative) @ $0 · Option exercise (M): 13,754 (derivative) @ $0 · +1 moreEDGAR
2026-08-124OYLER JOHN — Chief Executive Officer, DirectorSale (S): 67 @ $350 · Sale (S): 2,813 @ $351.80 · Sale (S): 3,673 @ $353.32 · Sale (S): 6,717 @ $354.78 · Sale (S): 3,476 @ $355.66 · Sale (S): 12,418 @ $356.62 · +18 moreEDGAR
2026-08-054Rosenberg Aaron — Chief Financial OfficerSale (S): 1,157 @ $312.71EDGAR
2026-08-034Lee Chan Henry — SVP, General CounselSale (S): 1,044 @ $323.69EDGAR
2026-07-244Lee Chan Henry — SVP, General CounselOption exercise (M): 514 @ $194.47 · Option exercise (M): 665 @ $213.32 · Option exercise (M): 490 @ $159.03 · Sale (S): 1,669 @ $325 · Option exercise (M): 6,682 (derivative) @ $0 · Option exercise (M): 8,645 (derivative) @ $0 · +1 moreEDGAR
2026-07-224OYLER JOHN — Chief Executive Officer, DirectorSale (S): 5,146 @ $310.08 · Sale (S): 6,273 @ $310.75 · Sale (S): 2,907 @ $311.80 · Option exercise (M): 33,990 @ $119.96 · Sale (S): 15,499 @ $312.29 · Sale (S): 14,326 @ $312.96 · +10 moreEDGAR
2026-07-174OYLER JOHN — Chief Executive Officer, DirectorOption exercise (M): 64,628 @ $119.96 · Sale (S): 1,440 @ $305.20 · Sale (S): 597 @ $306.96 · Sale (S): 680 @ $309.05 · Sale (S): 4,833 @ $310.37 · Sale (S): 5,543 @ $311.42 · +5 moreEDGAR
2026-07-174OYLER JOHN — Chief Executive Officer, DirectorOption exercise (M): 35,605 @ $100.04 · Option exercise (M): 76,677 @ $169.58 · Option exercise (M): 4,275 @ $160.40 · Sale (S): 6,067 @ $310.02 · Sale (S): 41,336 @ $310.92 · Sale (S): 12,857 @ $311.71 · +21 moreEDGAR
2026-07-144OYLER JOHN — Chief Executive Officer, DirectorSale (S): 4,139 @ $303.07 · Sale (S): 8,122 @ $303.93 · Option exercise (M): 97,282 @ $36.90 · Option exercise (M): 36,318 @ $100.04 · Sale (S): 39,090 @ $305.02 · Sale (S): 45,895 @ $306.21 · +4 moreEDGAR
2026-07-144OYLER JOHN — Chief Executive Officer, DirectorOption exercise (M): 11,698 @ $36.90 · Sale (S): 1,493 @ $296.07 · Sale (S): 1,314 @ $297.23 · Sale (S): 3,074 @ $298.35 · Sale (S): 5,143 @ $298.94 · Sale (S): 370 @ $300.12 · +13 moreEDGAR
2026-07-104Lee Chan Henry — SVP, General CounselOption exercise (M): 202 @ $194.47 · Option exercise (M): 266 @ $213.32 · Option exercise (M): 196 @ $159.03 · Sale (S): 664 @ $302.46 · Option exercise (M): 2,626 (derivative) @ $0 · Option exercise (M): 3,458 (derivative) @ $0 · +1 moreEDGAR
2026-06-254Wang Lai — President, Global Head of R&DSale (S): 1,068 @ $276.74EDGAR
2026-06-254Wu Xiaobin — President and COOSale (S): 1,292 @ $276.26EDGAR
2026-06-254OYLER JOHN — Chief Executive Officer, DirectorSale (S): 1,800 @ $273.30 · Sale (S): 1,290 @ $274.12 · Sale (S): 320 @ $275.10EDGAR
2026-06-184Lee Chan Henry — SVP, General CounselSale (S): 590 @ $265.98EDGAR
2026-06-184Wang Lai — President, Global Head of R&DSale (S): 1,169 @ $265.39EDGAR
2026-06-184Wu Xiaobin — President and COOSale (S): 1,357 @ $266.76EDGAR
2026-06-184OYLER JOHN — Chief Executive Officer, DirectorSale (S): 1,650 @ $264.87 · Sale (S): 1,710 @ $265.99 · Sale (S): 333 @ $266.69EDGAR
2026-06-154Mooney Elizabeth Fisher — DirectorGrant/award (A): 18,980 @ $0EDGAR
2026-06-154Sawyers Charles Lazelle — DirectorGrant/award (A): 18,980 @ $0EDGAR
2026-06-154Rosenberg Aaron — Chief Financial OfficerGrant/award (A): 71,175 @ $0 · Sale (S): 631 @ $257.74 · Grant/award (A): 137,865 (derivative) @ $0EDGAR
2026-06-154Lee Chan Henry — SVP, General CounselGrant/award (A): 45,071 @ $0 · Sale (S): 428 @ $257.63 · Grant/award (A): 87,308 (derivative) @ $0EDGAR
2026-06-154Dugan Margaret — DirectorGrant/award (A): 18,980 @ $0EDGAR
2026-06-154Riva Alessandro — DirectorGrant/award (A): 18,980 @ $0EDGAR
2026-06-154Wang Lai — President, Global Head of R&DGrant/award (A): 118,625 @ $0 · Sale (S): 756 @ $261.00 · Grant/award (A): 229,775 (derivative) @ $0EDGAR
2026-06-154Wu Xiaobin — President and COOGrant/award (A): 118,625 @ $0 · Sale (S): 626 @ $261.20 · Grant/award (A): 229,775 (derivative) @ $0EDGAR
2026-06-154Ball Titus B. — Principal Accounting OfficerGrant/award (A): 31,213 @ $0 · Sale (S): 49 @ $256.39 · Sale (S): 120 @ $257.53EDGAR
2026-06-154Wang Xiaodong — DirectorGrant/award (A): 99,892 @ $0 · Grant/award (A): 193,492 (derivative) @ $0EDGAR
2026-06-154BRANDICOURT OLIVIER — DirectorGrant/award (A): 18,980 @ $0EDGAR
2026-06-154Sharp Shalini — DirectorGrant/award (A): 18,980 @ $0EDGAR
2026-06-154HOOPER ANTHONY C — DirectorGrant/award (A): 18,980 @ $0EDGAR
2026-06-154BAKER BROS. ADVISORS LP — Director
667, L.P. — Director
Baker Bros. Advisors (GP) LLC — Director
Baker Brothers Life Sciences LP — Director
BAKER FELIX — Director
BAKER JULIAN — Director
Grant/award (A): 18,980 @ $0 · Grant/award (A): 18,980 @ $0EDGAR
2026-06-154OYLER JOHN — Chief Executive Officer, DirectorGrant/award (A): 177,931 @ $0 · Sale (S): 741 @ $256.23 · Sale (S): 859 @ $257.59 · Sale (S): 200 @ $258.28 · Sale (S): 149 @ $258.81 · Grant/award (A): 344,669 (derivative) @ $0EDGAR
2026-06-104Lee Chan Henry — SVP, General CounselSale (S): 711 @ $270.24 · Sale (S): 160 @ $271.26EDGAR
2026-06-104Wang Lai — President, Global Head of R&DSale (S): 1,327 @ $269.34 · Sale (S): 40 @ $270.73EDGAR
2026-06-104Wu Xiaobin — President and COOSale (S): 1,444 @ $269.33 · Sale (S): 40 @ $270.55EDGAR
2026-06-104Ball Titus B. — Principal Accounting OfficerSale (S): 100 @ $271.06 · Sale (S): 36 @ $272.08EDGAR
2026-06-104OYLER JOHN — Chief Executive Officer, DirectorSale (S): 3,820 @ $270.38 · Sale (S): 1,120 @ $271.14EDGAR
2026-06-034Yi Qingqing — DirectorSale (S): 235 @ $279.13EDGAR
2026-05-274BAKER BROS. ADVISORS LP — Director
667, L.P. — Director
Baker Bros. Advisors (GP) LLC — Director
Baker Brothers Life Sciences LP — Director
BAKER FELIX — Director
BAKER JULIAN — Director
Sale (S): 2,743 @ $23.85 · Sale (S): 2,743 @ $23.85 · Sale (S): 2,756 @ $23.79 · Sale (S): 2,756 @ $23.79EDGAR

Recent 8-K events — BeOne Medicines Ltd.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-268-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-268-K8.01 — Other EventsEDGAR
2026-06-118-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-158-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-268-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-198-K1.02 — Termination of a Material Definitive AgreementEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ONC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs